Register today to receive your daily dose of health news. Get the latest information delivered to your inbox with our free dailyRx Newsletter!
Connect with the dailyRx social media channels to receive the latest health news and information and to stay up to date on dailyRx promotions!
Stay up to date with the health news that matters most! Choose from a wide selection of dailyRx Headlines™ news feeds and receive the latest headlines directly on your website as soon as news is published.
Explore our wide selection of money-saving coupons for medications and other health-related products.
Save money on your Rx medications with our printable and online medication discount card.
Learn how to reduce your medication costs with discount programs and other valuable savings resources directly from pharmaceutical companies.
Actemra (generic: tocilizumab) is a prescription medication used to treat rheumatoid arthritis (RA) in adults. It is also used to treat systemic juvenile idiopathic arthritis (SJIA) or polyarticular juvenile idiopathic arthritis (PJIA) in children 2 years or older.
Actemra is referred to as an interleukin-6, or IL-6, receptor inhibitor. IL-6 is a molecule produced by the body that binds to the IL-6 receptor and causes inflammation. Patients with arthritis have increased levels of IL-6 in their body. By blocking the IL-6 receptor, Actemra can decrease the symptoms of arthritis.
Actemra comes in an injectable form to be given directly into a vein (IV) by a healthcare provider. It is usually given once every 4 weeks for RA and PJIA or every 2 weeks for SJIA.
Common side effects of Actemra are cold-like symptoms, increased blood pressure, and headache.